- Companies
- ZO Skin Health
ZO Skin Health Acquisition, Valuation, Funding & Investors
ZO Skin Health was acquired by Galderma for $1.5B in October 2026, a 4.5x multiple on $330M of revenue.
ZO Skin Health revenue at acquisition
$330M
Last twelve months · Oct 2026
ZO Skin Health revenue multiple at acquisition
4.5x
EV/Revenue · Oct 2026
Cumulative funding ZO Skin Health raised
$6M
across 1 funding round
About ZO Skin Health
ZO Skin Health is an Irvine-headquartered skincare company developing physician-dispensed products and protocols for skin conditions worldwide. Founded by dermatologist Zein Obagi, it offers regimens addressing hyperpigmentation, acne, and aging via professional training programs and patient education resources.
Founded
2008
HQ
Website
Status
Acquired
Customer focus
B2B
Revenue model
Product sales
Revenue
$330M (Oct 2026)
Valuation
$1.5B (acquired Oct 2026)
Sectors
ZO Skin Health Acquisition
ZO Skin Health was acquired by Galderma for $1.5B on 14 October 2026.
The acquisition price implies a 4.5x revenue multiple on $330M of revenue.
Before the acquisition ZO Skin Health had raised $6M across 1 funding round.
Galderma signed an agreement on 14 October 2026 to acquire 100 percent of ZO Skin Health for an enterprise value of USD 1.5 billion in an all-cash transaction. The sellers are ZO's shareholders, including funds managed by Blackstone and the Obagi family. Galderma will fund the purchase from existing cash reserves and bank financing, and expects closing in the fourth quarter of 2026 or early 2027, subject to regulatory approvals. The company said ZO complements its Alastin brand and expands its Dermatological Skincare portfolio, which also includes Cetaphil, in the physician-dispensed segment. ZO Skin Health was founded by dermatologist Dr. Zein Obagi and is headquartered in Irvine, California. It offers more than 40 products built around retinol and acid-based daily regimens, manufactured in the United States, and sells through more than 16,500 physician, medical spa and online accounts in more than 40 countries. It recorded net sales of approximately USD 330 million in the twelve months to June 2026.
| Acquirer | Date | Type | Price | EV/Revenue |
|---|---|---|---|---|
| 14 Oct 2026 | Strategic M&A | $1.5B | 4.5x |
Sources: galderma.com, wsj.com
ZO Skin Health Funding History
ZO Skin Health has raised a total of $6M across 1 funding round.
ZO Skin Health funding rounds
| Date | Stage | Raised |
|---|---|---|
| Feb 2015 | Series A | $6M |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialZO Skin Health Competitors
ZO Skin Health competitors include listed companies like Intercos, Zydus Wellness, Harbin Fuerjia Technology and Honasa Consumer, and private ones like Eight Sleep and Lush Fresh Handmade Cosmetics.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Private | - | - | $1.5B | - | ||
| Private | - | - | $1.5B | - | ||
| Publicly listed | $1.2B | $155M | $1.4B | 1.3x | ||
| Publicly listed | $419M | $50M | $1.6B | 3.7x | ||
| Publicly listed | $284M | $92M | $1.6B | 3.1x | ||
| Publicly listed | $254M | $27M | $1.6B | 5.4x |
ZO Skin Health Public Comps
ZO Skin Health is no longer listed, but its public comps include Intercos, Zydus Wellness, Harbin Fuerjia Technology, Honasa Consumer, Amorepacific Group, Jamieson Wellness, SILICON2, Natura Cosmeticos, Faes Farma and Edgewell.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $1.2B | $155M | 1.3x | 1.3x | 10.2x | 8.7x | |||
| $419M | $50M | 4.5x | 3.7x | 37.6x | 26.7x | |||
| $284M | $92M | 3.7x | 3.1x | 11.5x | 11.0x | |||
| $254M | $27M | 6.1x | 5.4x | 58.0x | 46.9x | |||
| $3.4B | $500M | 1.0x | - | 6.5x | - | |||
| $587M | $94M | 2.9x | 2.6x | 17.9x | 13.4x | |||
| $825M | $171M | 1.6x | 1.2x | 7.8x | 6.2x | |||
| $4B | $334M | 0.5x | 0.5x | 6.3x | 4.2x | |||
This data is available for Pro users. Sign up to see all ZO Skin Health competitors and their valuation data. Start Free Trial | ||||||||
Common questions about ZO Skin Health
| When was ZO Skin Health founded? | ZO Skin Health was founded in 2008. |
| Where is ZO Skin Health headquartered? | ZO Skin Health is headquartered in Los Angeles, CA, United States. |
| Is ZO Skin Health publicly listed? | No, ZO Skin Health was acquired by Galderma in October 2026. |
| Who acquired ZO Skin Health? | ZO Skin Health was acquired by Galderma in October 2026. |
| How much was ZO Skin Health acquired for? | ZO Skin Health was acquired for $1.5B in October 2026, a 4.5x revenue multiple. |
| How much funding has ZO Skin Health raised? | ZO Skin Health has raised $6M across 1 funding round. |
| What was ZO Skin Health's last funding round? | ZO Skin Health's last funding round was a $6M Series A in February 2015. |
| Which companies are comparable to ZO Skin Health? | Companies comparable to ZO Skin Health include Eight Sleep, Lush Fresh Handmade Cosmetics, Intercos, Zydus Wellness, Harbin Fuerjia Technology and Honasa Consumer. |
See companies similar to ZO Skin Health
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




